Sciwind Biosciences Co., Ltd. ("Sciwind"), a biopharmaceutical company focused on the discovery and development of innovative therapies for metabolic diseases, announced today that China's National ...

SHANGHAI, SHANGHAI, CHINA, January 21, 2026 /EINPresswire.com/ -- As the global demand for precision manufacturing ...

PECONDLE® (picankibart injection) has received approval from China's National Medical Products Administration (NMPA) for the treatment of moderate-to-severe plaque psoriasis in adult patients who are ...

Industry Trends and Growing Demand for Primary Current Injection Testing Power systems worldwide are undergoing ...

Nylon is one of the most widely used engineering thermoplastics due to its excellent mechanical properties, such as high ...

TABOSUN ® (ipilimumab N01 injection) has been approved in combination with TYVYT ® (sintilimab injection) for the neoadjuvant treatment of patients with stage IIB-III resectable microsatellite ...

Jan 30 (Reuters) - China is considering the sale of hundreds of billions of yuan in special government bonds to recapitalise some of its largest insurers, Bloomberg News reported on Friday citing ...

SAN FRANCISCO and SUZHOU, China, Dec. 25, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

SAN FRANCISCO and SUZHOU, China, Nov. 25, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...